These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Effect of arteparon on the formation of calcium phosphate and calcium pyrophosphate crystals--comparative experimental study]. Sárközi AM; Németh-Csóka M Z Rheumatol; 1984; 43(1):30-5. PubMed ID: 6324513 [TBL] [Abstract][Full Text] [Related]
4. Bone pyrophosphate in uremia and its association with extraosseous calcification. Alfrey AC; Solomons CC J Clin Invest; 1976 Mar; 57(3):700-5. PubMed ID: 175092 [TBL] [Abstract][Full Text] [Related]
5. Role of the progressive ankylosis gene in cartilage mineralization. Zaka R; Williams CJ Curr Opin Rheumatol; 2006 Mar; 18(2):181-6. PubMed ID: 16462526 [TBL] [Abstract][Full Text] [Related]
6. [Physico-chemical studies on the interaction of hydroxyapatite with biologically significant ions]. Shimabayashi S Yakugaku Zasshi; 1987 May; 107(5):323-37. PubMed ID: 2821220 [No Abstract] [Full Text] [Related]
7. The role of inorganic pyrophosphate in aortic valve calcification. Rathan S; Yoganathan AP; O'Neill CW J Heart Valve Dis; 2014 Jul; 23(4):387-94. PubMed ID: 25803964 [TBL] [Abstract][Full Text] [Related]
8. Pathological calcification and replicating calcifying-nanoparticles: general approach and correlation. Ciftçioğlu N; McKay DS Pediatr Res; 2010 May; 67(5):490-9. PubMed ID: 20094006 [TBL] [Abstract][Full Text] [Related]
9. Role of phosphate and pyrophosphate in soft tissue calcification. Alfrey AC; Ibels LS Adv Exp Med Biol; 1978; 103():187-93. PubMed ID: 213949 [No Abstract] [Full Text] [Related]
10. Advances in understanding calcium-containing crystal disease. Ea HK; Lioté F Curr Opin Rheumatol; 2009 Mar; 21(2):150-7. PubMed ID: 19339926 [TBL] [Abstract][Full Text] [Related]
11. Clinical aspects of basic calcium phosphate crystal deposition. Halverson PB; McCarty DJ Rheum Dis Clin North Am; 1988 Aug; 14(2):427-39. PubMed ID: 3051158 [TBL] [Abstract][Full Text] [Related]
12. Pyrophosphate and diphosphonates in skeletal metabolism. Physiological, clinical and therapeutic aspects. Russell RG; Fleisch H Clin Orthop Relat Res; 1975 May; (108):241-63. PubMed ID: 166785 [TBL] [Abstract][Full Text] [Related]
13. Inorganic pyrophosphate concentrations in the synovial fluid of arthritic patients. McCarty DJ; Solomon SD; Warnock ML; Paloyan E J Lab Clin Med; 1971 Aug; 78(2):216-29. PubMed ID: 4327881 [No Abstract] [Full Text] [Related]
14. Pyrophosphates as a major inhibitor of matrix calcification in Pseudoxanthoma elasticum. Dabisch-Ruthe M; Kuzaj P; Götting C; Knabbe C; Hendig D J Dermatol Sci; 2014 Aug; 75(2):109-20. PubMed ID: 24907773 [TBL] [Abstract][Full Text] [Related]
15. Phosphate-induced vascular calcification: role of pyrophosphate and osteopontin. Lomashvili KA; Cobbs S; Hennigar RA; Hardcastle KI; O'Neill WC J Am Soc Nephrol; 2004 Jun; 15(6):1392-401. PubMed ID: 15153550 [TBL] [Abstract][Full Text] [Related]
16. Cartilage calcification: normal and aberrant. Boskey AL; Bullough PG Scan Electron Microsc; 1984; (Pt 2):943-52. PubMed ID: 6091260 [TBL] [Abstract][Full Text] [Related]
17. Normal and abnormal mineralization in mammals. Anderson HC Trans Am Soc Artif Intern Organs; 1981; 27():702-8. PubMed ID: 7331160 [TBL] [Abstract][Full Text] [Related]
18. [A clinical study of calcium pyrophosphate dihydrate crystal deposition disease]. Ogata M Nihon Seikeigeka Gakkai Zasshi; 1985 Aug; 59(8):819-34. PubMed ID: 3003215 [TBL] [Abstract][Full Text] [Related]
19. Prevention of vascular calcification: is pyrophosphate therapy a solution? Persy VP; McKee MD Kidney Int; 2011 Mar; 79(5):490-3. PubMed ID: 21321558 [TBL] [Abstract][Full Text] [Related]
20. Pyrophosphate and diphosphonates in calcium metabolism and their possible role in renal failure. Russell RG; Bisaz S; Fleisch H Arch Intern Med; 1969 Nov; 124(5):571-7. PubMed ID: 4310762 [No Abstract] [Full Text] [Related] [Next] [New Search]